Ortho-Novum 10/11--a new "bi-phasic" oral contraceptive
Medical Letter on Drugs and Therapeutics 24(620): 93-94
1982
ISSN/ISBN: 0025-732X PMID: 7121396 Document Number: 427455
Document emailed within 1 workday
Related Documents
Caruso, S.; Agnello, C.; Romano, M.; Cianci, S.; Lo Presti, L.; Malandrino, C.; Cianci, A. 2011: Preliminary study on the effect of four-phasic estradiol valerate and dienogest (E2V/DNG) oral contraceptive on the quality of sexual life Journal of Sexual Medicine 8(10): 2841-2850Ndefo, U.Anadu.; Mosely, N. 2010: Estradiol valerate and estradiol valerate/dienogest (natazia) tablets: the first four-phasic oral contraceptive P and T: a Peer-Reviewed Journal for Formulary Management 35(11): 614-617
Vasilenko, N.M.; Labunskiĭ, V.V. 1971: Comparative toxicological characteristics of para- and ortho-aminophenols, para-chloro-ortho-aminophenol and para-nitro-ortho-aminophenol Farmakologiia i Toksikologiia 34(6): 730-733
Láznícek, M.; Kvĕtina, J.; Mazák, J.; Krch, V.; Kvĕtinová, M.; Srámek, B. 1987: Changes in plasma binding of ortho-iodobenzoate and ortho-iodohippuran in patients with kidney and liver diseases Ceskoslovenska Farmacie 36(3): 97-102
Pershin, S.M. 2010: Weak coherent radiation of OH and ortho- H2O space masers as a carrier in biocommunication: the ortho/para-conversion of H2O spin isomers? Biofizika 55(4): 619-625
Rushton, L.; Jones, D.R. 1992: Oral contraceptive use and breast cancer risk: a meta-analysis of variations with age at diagnosis, parity and total duration of oral contraceptive use British Journal of Obstetrics and Gynaecology 99(3): 239-246
Kaul, L.; Ahluwalia, B. 1978: Interrelation of caffeine and oral contraceptive steroid metabolism in hypertensive oral contraceptive users in humans Journal of Steroid Biochemistry 9(9): 862-863
Harel, Z.; Riggs, S.; Vaz, R.; Flanagan, P.; Dunn, K.; Harel, D. 2005: Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra Journal of Pediatric and Adolescent Gynecology 18(2): 85-90
Kuhnz, W.; al-Yacoub, G.; Fuhrmeister, A. 1992: Pharmacokinetics of levonorgestrel and ethinylestradiol in 9 women who received a low-dose oral contraceptive over a treatment period of 3 months and, after a wash-out phase, a single oral administration of the same contraceptive formulation Contraception 46(5): 455-469
Trujillo-de Santiago, G.; Patricio Sáenz-Collins, C.; García-Arellano, L.; Moisés Álvarez, M. 2014: Mathematical modeling of the release of active ingredients from a contraceptive patch: ortho evra(®) as a case study Iranian Journal of Pharmaceutical Research: Ijpr 13(1): 39-48
Mauck, C.; Callahan, M.; Weiner, D.H.; Dominik, R.; Fc, I.G. 1999: A comparative study of the safety and efficacy of FemCap®, a new vaginal barrier contraceptive, and the ortho All-Flex® diaphragm Contraception (Stoneham) 60(2): 71-80
Samy Suissa; Brenda Hemmelgarn; Walter, O. Spitzer; James Brophy; Jean-Paul Collet; Robert Cǒte; Winanne Downey; Lindsay Edouard; Jacques Leclerc; Ora Paltiel 1993: The Saskatchewan oral contraceptive cohort study of oral contraceptive use and cardiovascular risks Pharmacoepidemiology and Drug Safety 2(1): 33-49
Gingnell, M.; Engman, J.; Frick, A.; Moby, L.; Wikström, J.; Fredrikson, M.; Sundström-Poromaa, I. 2013: Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill--a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive Psychoneuroendocrinology 38(7): 1133-1144
Audet, M.C.; Moreau, M.; Koltun, W.D.; Waldbaum, A.S.; Shangold, G.; Fisher, A.C.; Creasy, G.W. 2001: Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial JAMA 285(18): 2347-2354
Mansour, D.; Verhoeven, C.; Sommer, W.; Weisberg, E.; Taneepanichskul, S.; Melis, G.B.; Sundström-Poromaa, I.; Korver, T. 2011: Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 16(6): 430-443
Lee, H.; Petrofsky, J.S.; Daher, N.; Berk, L.; Laymon, M. 2014: Differences in anterior cruciate ligament elasticity and force for knee flexion in women: oral contraceptive users versus non-oral contraceptive users European Journal of Applied Physiology 114(2): 285-294
Lee, H.; Petrofsky, J.S.; Daher, N.; Berk, L.; Laymon, M. 2014: Differences in anterior cruciate ligament elasticity and force for knee flexion in women: oral contraceptive users versus non-oral contraceptive users European Journal of Applied Physiology 114(2): 285-294
Davis, S.R.; Bitzer, J.; Giraldi, A.; Palacios, S.; Parke, S.; Serrani, M.; Mellinger, U.; Nappi, R.E. 2013: Change to either a nonandrogenic or androgenic progestin-containing oral contraceptive preparation is associated with improved sexual function in women with oral contraceptive-associated sexual dysfunction Journal of Sexual Medicine 10(12): 3069-3079
Sibai, B.M.; Odlind, V.; Meador, M.L.; Shangold, G.A.; Fisher, A.C.; Creasy, G.W. 2002: A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra/Evra) Fertility and Sterility 77(2 Suppl 2: S19-S26
Archer, D.F.; Bigrigg, A.; Smallwood, G.H.; Shangold, G.A.; Creasy, G.W.; Fisher, A.C. 2002: Assessment of compliance with a weekly contraceptive patch (Ortho Evra/Evra) among North American women Fertility and Sterility 77(2 Suppl. 2): S27-S31